March 12 | Campus
Kellogg Partnership Blends Business, Science
The gap between business and science is getting smaller. To address that reality the Kellogg School of Management and Johns Hopkins Medicine are joining forces to offer a series of new educational programs on the business of life science.
“These innovative programs are a direct result of the collaboration of faculty from both schools,” said Dipak C. Jain, dean of the Kellogg School. “There is a need for courses like this for scientists and managers in the biotechnology and pharmaceutical fields, and we are excited to partner with Johns Hopkins Medicine to provide the necessary education for these professionals.”
Edward D. Miller, CEO of Johns Hopkins Medicine and dean of Johns Hopkins Medical School notes that “Bringing science and business together from these two top institutions will provide participants with a thorough and practical understanding of how to move forward with their ventures.”
The executive education courses begin in March with Business for Scientists, a three-part certificate program designed to introduce scientists, research faculty, post-doctoral fellows and doctoral students from Johns Hopkins to business concepts and industry specific tools and frameworks. Topics such as accounting, strategy, finance, marketing, and management and its relevance to the biomedical sector will be covered. Kellogg faculty also will walk participants through the process of building and managing a biotechnology firm.
The second program offered is Science for Managers, also a certificate program, which teaches participants concepts in physiology, disease, drug design and regulatory affairs. The course is designed for investors, venture capitalists, business development executives, consultants, analysts or government officials involved in making legislative decisions concerning biotechnology. This program will be taught by faculty from Kellogg, the Feinberg School of Medicine, the Weinberg College of Arts and Sciences and Johns Hopkins Medicine.
The third program will be a course designed for chief executive officers of biotechnology and pharmaceutical companies. The one-day program is designed to provide participants with fresh ways of thinking and will creatively address issues in the biomedical industry. Focusing on new concepts developed by the faculty from Johns Hopkins Medicine and Kellogg, the program enables participants to extend, renew and invigorate strategic thinking in the biomedical sector.
Finally, a non-degree exchange program between the two schools is planned for the fall, which will allow for student exchanges between Kellogg and Johns Hopkins University.
For more information, go to http://www.kellogg.northwestern.edu/academic/biotech/program/execed.htm